US Patent 8133488 Methods and compositions for targeting polyubiquitin
Patent 8133488 was granted and assigned to Genentech on March, 2012 by the United States Patent and Trademark Office.
All edits
Edits on 28 Nov, 2023
Golden AI
Edits made to:
Article (+119 characters)
Article
Patent abstract
Anti-K63-linked polyubiquitin monoclonal antibodies, and methods for using the antibodies, are provided.
Edits on 13 Sep, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 20 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 08133488 Methods and compositions for targeting polyubiquitin US Patent 8133488 Methods and compositions for targeting polyubiquitin
Infobox
Patent Number
0813348800
Patent Number
813348800
Edits on 23 Apr, 2023
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
081334880
Date of Patent
March 13, 2012
0Patent Application Number
123555310
Date Filed
January 16, 2009
0Patent Primary Examiner
Edits on 28 Sep, 2022
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
081334880
Date of Patent
March 13, 2012
0Patent Application Number
123555310
Date Filed
January 16, 2009
0Patent Primary Examiner
Edits on 14 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 08133488 Methods and compositions for targeting polyubiquitin
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
08133488
Date of patent
March 13, 2012
Patent application number
12355531
Date Filed
January 16, 2009
Patent primary examiner
Find more entities like US Patent 8133488 Methods and compositions for targeting polyubiquitin
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
